Search Results - "Shindo, Yuichiro"

Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

Authors: Shindo, Yuichiro Piao, Yi Berry, Mark et al.

Source: Viruses (1999-4915). Apr2026, Vol. 18 Issue 4, p479. 10p.

Association between immunity and antimicrobial treatment resistance in patients with Mycobacterium avium complex pulmonary disease: a multicenter observational study.

Authors: Matsuura, Akinobu Shindo, Yuichiro Sugiyama, Daisuke et al.

Source: BMC Infectious Diseases. 10/23/2025, Vol. 25 Issue 1, p1-15. 15p.

Factors associated with adverse drug reactions or death in very elderly hospitalized patients with pulmonary tuberculosis.

Authors: Yagi, Mitsuaki Shindo, Yuichiro Mutoh, Yoshikazu et al.

Source: Scientific Reports. 4/26/2023, Vol. 13 Issue 1, p1-10. 10p.

Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia.

Authors: Murakami, Yasushi Shindo, Yuichiro Sano, Masahiro et al.

Source: Scientific Reports. 8/26/2022, Vol. 12 Issue 1, p1-11. 11p.

Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure.

Authors: Shindo, Yuichiro Kondoh, Yasuhiro Kada, Akiko et al.

Source: Infectious Diseases & Therapy. Dec2021, Vol. 10 Issue 4, p2353-2369. 17p.

Inhalation adherence for asthma and COPD improved during the COVID-19 pandemic: a questionnaire survey at a university hospital in Japan.

Authors: Fukutani, Eriko Wakahara, Keiko Nakamura, Saya et al.

Source: Journal of Asthma. Nov2023, Vol. 60 Issue 11, p2002-2013. 12p.

Subjects: COVID-19 pandemic, Change (Psychology), Hospital surveys, Chronic obstructive pulmonary disease, University hospitals, Premature menopause

Geographic Terms: Japan

Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens.

Authors: Kobayashi, Hironori Shindo, Yuichiro Kobayashi, Daisuke et al.

Source: International Journal of Infectious Diseases. Nov2022, Vol. 124, p124-132. 9p.

Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia.

Authors: Sano, Masahiro Shindo, Yuichiro Takahashi, Kunihiko et al.

Source: Journal of Infection & Chemotherapy (Elsevier Inc.). Jun2022, Vol. 28 Issue 6, p745-752. 8p.

Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.

Authors: Matsumura, Yasufumi Shindo, Yuichiro Iinuma, Yoshitsugu et al.

Source: BMC Infectious Diseases. 2011, Vol. 11 Issue 1, p76-84. 9p.

Mortality in patients with community‐onset pneumonia at low risk of drug‐resistant pathogens: Impact of β‐lactam plus macrolide combination therapy.

Authors: Okumura, Junya Shindo, Yuichiro Takahashi, Kunihiko et al.

Source: Respirology. May2018, Vol. 23 Issue 5, p526-534. 9p. 1 Diagram, 3 Charts, 1 Graph.

Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians.

Authors: Shindo, Yuichiro Hasegawa, Yoshinori

Source: Respirology. Nov2017, Vol. 22 Issue 8, p1536-1546. 11p.

Anti-PD-L1 peptide improves survival in sepsis.

Authors: Shindo, Yuichiro McDonough, Jacquelyn S. Chang, Katherine C. et al.

Source: Journal of Surgical Research. Feb2017, Vol. 208, p33-39. 7p.

Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study.

Authors: Shindo, Yuichiro Ito, Ryota Kobayashi, Daisuke et al.

Source: Lancet Infectious Diseases. Sep2015, Vol. 15 Issue 9, p1055-1065. 11p.

Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Authors: Kita, Toshihiro Ohmagari, Norio Saito, Sho et al.

Source: Viruses (1999-4915). Jul2025, Vol. 17 Issue 7, p982. 14p.

Health-Care-Associated Pneumonia Among Hospitalized Patients in a Japanese Community Hospital.

Authors: Shindo, Yuichiro Sato, Shinji Maruyama, Eiichi et al.

Source: CHEST. Mar2009, Vol. 135 Issue 3, p633-640. 8p. 6 Charts.

Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia.

Authors: SHINDO, Yuichiro SATO, Shinji MARUYAMA, Eiichi et al.

Source: Respirology. Jul2008, Vol. 13 Issue 5, p731-735. 5p. 2 Charts, 1 Graph.

Failure of non-invasive respiratory support after 6 hours from initiation is associated with ICU mortality.

Authors: Nishikimi, Mitsuaki Nishida, Kazuki Shindo, Yuichiro et al.

Source: PLoS ONE. 4/30/2021, Vol. 16 Issue 4, p1-13. 13p.

Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection.

Authors: Nasrin, Shamima Hegerle, Nicolas Sen, Shaichi et al.

Source: BMC Microbiology. 1/6/2022, Vol. 22 Issue 1, p1-12. 12p.

Risk Factors of Resistant Pathogens for β-Lactam Plus Macrolide, or Fluoroquinolone in Patients With CAP and HCAP: A Multicenter Prospective Observational Study Among Hospitalized Patients With CAP, HCAP, and HAP in Japan (CJLSG 0911).

Authors: Shindo, Yuichiro Ito, Ryota Kobayashi, Daisuke et al.

Source: CHEST. Oct2012 Supplement, Vol. 142, p150A-150C. 1p.

Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission.

Authors: Andruska, Adam Micek, Scott T. Shindo, Yuichiro et al.

Source: CHEST. Jul2015, Vol. 148 Issue 1, p103-111. 9p.